Literature DB >> 21174543

Role of IKKα in skin squamous cell carcinomas.

Eunmi Park1, Bigang Liu, Xiaojun Xia, Feng Zhu, Willette-Brown Jami, Yinling Hu.   

Abstract

Squamous cell carcinoma (SCC) and basal cell carcinoma (BCC) are two major types of skin cancer derived from keratinocytes. SCC is a more aggressive type of cancer than BCC in humans. One significant difference between SCC and BCC is that SCC development is generally associated with cell dedifferentiation and morphological changes. When SCC is converted to spindle cell carcinoma, the latest stage of cancer, the tumor cells change to a fibroblastic cell morphology (epithelial-to-mesenchymal transition) and lose their differentiation markers. Recently, several laboratories have reported altered IκB kinase α (IKKα) protein localization, downregulated IKKα, and IKKα gene deletions and mutations in human SCCs of the skin, lung, esophagus, and neck and head. In addition, IKKα reduction promotes chemical carcinogen- and ultraviolet B-induced skin carcinogenesis, and IKKα deletion in keratinocytes causes spontaneous skin SCCs, but not BCCs, in mice. Thus, IKKα emerges as a bona fide skin tumor suppressor. In this article, we will discuss the role of IKKα in skin SCC development.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21174543      PMCID: PMC7365019          DOI: 10.2217/fon.10.166

Source DB:  PubMed          Journal:  Future Oncol        ISSN: 1479-6694            Impact factor:   3.404


  79 in total

Review 1.  The Myc/Max/Mad network and the transcriptional control of cell behavior.

Authors:  C Grandori; S M Cowley; L P James; R N Eisenman
Journal:  Annu Rev Cell Dev Biol       Date:  2000       Impact factor: 13.827

2.  IKK1-deficient mice exhibit abnormal development of skin and skeleton.

Authors:  Q Li; Q Lu; J Y Hwang; D Büscher; K F Lee; J C Izpisua-Belmonte; I M Verma
Journal:  Genes Dev       Date:  1999-05-15       Impact factor: 11.361

3.  Carcinogen-specific mutation and amplification of Ha-ras during mouse skin carcinogenesis.

Authors:  M Quintanilla; K Brown; M Ramsden; A Balmain
Journal:  Nature       Date:  1986 Jul 3-9       Impact factor: 49.962

4.  IKKalpha controls formation of the epidermis independently of NF-kappaB.

Authors:  Y Hu; V Baud; T Oga; K I Kim; K Yoshida; M Karin
Journal:  Nature       Date:  2001-04-05       Impact factor: 49.962

5.  IKKalpha enhances human keratinocyte differentiation and determines the histological variant of epidermal squamous cell carcinomas.

Authors:  Rodolfo Moreno-Maldonado; Angel Ramírez; Manuel Navarro; M Jesús Fernández-Aceñero; Concepción Villanueva; Angustias Page; José L Jorcano; Ana Bravo; M Llanos Casanova
Journal:  Cell Cycle       Date:  2008-04-11       Impact factor: 4.534

6.  Epigenetic inactivation of IkappaB Kinase-alpha in oral carcinomas and tumor progression.

Authors:  Genta Maeda; Tadashige Chiba; Shuichi Kawashiri; Tazuko Satoh; Kazushi Imai
Journal:  Clin Cancer Res       Date:  2007-09-01       Impact factor: 12.531

7.  An activated Harvey ras oncogene produces benign tumours on mouse epidermal tissue.

Authors:  D R Roop; D R Lowy; P E Tambourin; J Strickland; J R Harper; M Balaschak; E F Spangler; S H Yuspa
Journal:  Nature       Date:  1986 Oct 30-Nov 5       Impact factor: 49.962

8.  An inducible mouse model for skin cancer reveals distinct roles for gain- and loss-of-function p53 mutations.

Authors:  Carlos Caulin; Thao Nguyen; Gene A Lang; Thea M Goepfert; Bill R Brinkley; Wei-Wen Cai; Guillermina Lozano; Dennis R Roop
Journal:  J Clin Invest       Date:  2007-07       Impact factor: 14.808

9.  Patterns of somatic mutation in human cancer genomes.

Authors:  Christopher Greenman; Philip Stephens; Raffaella Smith; Gillian L Dalgliesh; Christopher Hunter; Graham Bignell; Helen Davies; Jon Teague; Adam Butler; Claire Stevens; Sarah Edkins; Sarah O'Meara; Imre Vastrik; Esther E Schmidt; Tim Avis; Syd Barthorpe; Gurpreet Bhamra; Gemma Buck; Bhudipa Choudhury; Jody Clements; Jennifer Cole; Ed Dicks; Simon Forbes; Kris Gray; Kelly Halliday; Rachel Harrison; Katy Hills; Jon Hinton; Andy Jenkinson; David Jones; Andy Menzies; Tatiana Mironenko; Janet Perry; Keiran Raine; Dave Richardson; Rebecca Shepherd; Alexandra Small; Calli Tofts; Jennifer Varian; Tony Webb; Sofie West; Sara Widaa; Andy Yates; Daniel P Cahill; David N Louis; Peter Goldstraw; Andrew G Nicholson; Francis Brasseur; Leendert Looijenga; Barbara L Weber; Yoke-Eng Chiew; Anna DeFazio; Mel F Greaves; Anthony R Green; Peter Campbell; Ewan Birney; Douglas F Easton; Georgia Chenevix-Trench; Min-Han Tan; Sok Kean Khoo; Bin Tean Teh; Siu Tsan Yuen; Suet Yi Leung; Richard Wooster; P Andrew Futreal; Michael R Stratton
Journal:  Nature       Date:  2007-03-08       Impact factor: 49.962

10.  Expression of COX-2, NF-kappaB-p65, NF-kappaB-p50 and IKKalpha in malignant and adjacent normal human colorectal tissue.

Authors:  M P Charalambous; T Lightfoot; V Speirs; K Horgan; N J Gooderham
Journal:  Br J Cancer       Date:  2009-06-09       Impact factor: 7.640

View more
  4 in total

1.  Regulation of epidermal differentiation through KDF1-mediated deubiquitination of IKKα.

Authors:  Yuanyuan Li; Liangfeng Tang; Jiping Yue; Xuewen Gou; Anning Lin; Scott D Weatherbee; Xiaoyang Wu
Journal:  EMBO Rep       Date:  2020-04-01       Impact factor: 8.807

Review 2.  The pivotal role of TBK1 in inflammatory responses mediated by macrophages.

Authors:  Tao Yu; Young-Su Yi; Yanyan Yang; Jueun Oh; Deok Jeong; Jae Youl Cho
Journal:  Mediators Inflamm       Date:  2012-12-06       Impact factor: 4.711

3.  Aberrant IKKα and IKKβ cooperatively activate NF-κB and induce EGFR/AP1 signaling to promote survival and migration of head and neck cancer.

Authors:  L K Nottingham; C H Yan; X Yang; H Si; J Coupar; Y Bian; T-F Cheng; C Allen; P Arun; D Gius; L Dang; C Van Waes; Z Chen
Journal:  Oncogene       Date:  2013-03-04       Impact factor: 9.867

4.  LGR5 expression is controled by IKKα in basal cell carcinoma through activating STAT3 signaling pathway.

Authors:  Jiantao Jia; Ying Shi; Bin Yan; Deshen Xiao; Weiwei Lai; Yu Pan; Yiqun Jiang; Ling Chen; Chao Mao; Jian Zhou; Sichuan Xi; Ya Cao; Shuang Liu; Yongguang Tao
Journal:  Oncotarget       Date:  2016-05-10
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.